Skip to main content
. 2010 Jul-Sep;2(3):223–228. doi: 10.4103/0975-1483.66792

Figure 4.

Figure 4

Plasma concentration time profile of zopiclone after oral, IV and IP administrations [Key: ■oral suspension administration; ♦intravenous solution administration; ▲intraperitoneal microsphere administration)